301393 昊帆生物
按盤價 
45.270 +0.940 (+2.120%)
45.270 +0.940 (+2.120%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.326 | 7.347 | 30.268 | 35.176 | 30.980 |
| 總資產報酬率 ROA (%) | 4.168 | 6.857 | 24.292 | 28.250 | 24.969 |
| 投入資產回報率 ROIC (%) | 4.297 | 7.241 | 28.561 | 33.292 | 29.667 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.628 | 38.553 | 43.258 | 46.443 | 46.822 |
| 營業利潤率 (%) | 33.823 | 28.952 | 33.353 | 34.958 | 19.351 |
| 息稅前利潤/營業總收入 (%) | 26.105 | 21.907 | 32.397 | 35.409 | 21.059 |
| 淨利潤/營業總收入 (%) | 29.356 | 25.457 | 28.912 | 30.154 | 14.309 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.060 | 97.992 | 98.457 | 98.713 | 96.115 |
| 價值變動淨收益/利潤總額(%) | 8.784 | 1.541 | 0.265 | 0.915 | 1.674 |
| 營業外收支淨額/利潤總額(%) | -0.404 | -0.068 | -0.191 | -0.075 | -0.036 | 償債能力分析 |
| 流動比率 (X) | 23.411 | 29.832 | 3.226 | 3.421 | 3.601 |
| 速動比率 (X) | 22.195 | 28.085 | 2.188 | 2.491 | 2.691 |
| 資產負債率 (%) | 4.030 | 3.283 | 19.627 | 19.894 | 19.400 |
| 帶息債務/全部投入資本 (%) | 0.374 | 0.158 | 3.600 | 4.187 | 2.330 |
| 股東權益/帶息債務 (%) | 26,512.845 | 62,960.856 | 2,631.580 | 2,241.845 | 4,110.054 |
| 股東權益/負債合計 (%) | 2,381.108 | 2,946.103 | 409.499 | 402.652 | 415.465 |
| 利息保障倍數 (X) | -3.443 | -3.119 | -36.296 | 74.123 | 12.278 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 65.182 | 51.630 | 47.038 | 50.348 | 47.898 |
| 存貨周轉天數 (天) | 153.810 | 172.124 | 136.362 | 119.462 | 125.693 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
